Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $3.77 Analyst target: $36.33 Upside: 863.66%
SCYNEXIS, Inc., a biotechnology company, offers therapies for the treatment of yeast infections in the United States. The company is headquartered in Jersey City, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.